Labbé-Jullié C, Blanot D, Morgat J L, Kitabgi P, Checler F, Vincent J P, Granier C, Van Rietschoten J
Biochimie. 1983 Oct;65(10):553-62. doi: 10.1016/s0300-9084(83)80105-9.
In this second paper on the synthesis of neurotensin analogues as precursors for radiolabelling, solid phase synthesis of two polyunsaturated peptides, [Dah6, delta Pro7,10]-neurotensin and acetyl-[delta Pro10]-neurotensin-(8-13), are described. The first one contains one triple bond and two double bonds susceptible to tritiation in the same molecule, the second one contains one double bond in the shortest sequence having neurotensin activity. The C-terminal residue, Boc-Leu, was esterified on the chloromethyl-resin by its cesium salt. For the other amino acids a double coupling was carried out, the first one with dicyclohexylcarbodimide and the second one with the amino acid hydroxybenzotriazole ester. Acylation of the second amino acid, on the resin, presented some difficulties to achieve completeness and several acetylations and benzoylations had to be performed in order to block the last 4 per cent of free amines. It seems that these difficulties are related to some batches of chloromethyl-resin. Incorporation of both acetylenic lysine, N alpha-Boc-N epsilon-Z-L-2,6-diamino-4-hexynoic acid, whose synthesis is described, and N alpha-Boc-L-3,4-dehydroproline was without problems in this synthesis. After cleavage by hydrofluoric acid the crude peptides were purified by gel filtration on Bio-Gel P2 and ion exchange chromatography on carboxymethylcellulose (CM 52). [Dah6, delta Pro7,10]-neurotensin so obtained (51 per cent compared to starting Boc-Leu-resin) was in homogeneous form as characterized by amino acid analysis, thin layer chromatography in different systems and high performance liquid chromatography. The hydrogenation or tritiation product was identical with native neurotensin. Unsaturated derivative and neurotensin obtained after catalytic hydrogenation were as active as native neurotensin in inhibition of 125I-[Trp11]-neurotensin binding to rat brain synaptic membranes and in guinea pig ileum contractility test. Substitution of proline and lysine by their dehydro-derivatives did not affect the biological properties of neurotensin. The tritiated neurotensin (160-180 Ci/mmol) should be a good agent for biological characterization of neurotensin receptors and for investigation of the peptide metabolism.
在这第二篇关于合成神经降压素类似物作为放射性标记前体的论文中,描述了两种多不饱和肽[Dah6,δPro7,10]-神经降压素和乙酰基-[δPro10]-神经降压素-(8 - 13)的固相合成。第一种在同一分子中含有一个三键和两个易被氚化的双键,第二种在具有神经降压素活性的最短序列中含有一个双键。C末端残基Boc - Leu通过其铯盐在氯甲基树脂上进行酯化。对于其他氨基酸,进行了双偶联,第一次用二环己基碳二亚胺,第二次用氨基酸羟基苯并三唑酯。树脂上第二个氨基酸的酰化在实现完全反应方面存在一些困难,必须进行几次乙酰化和苯甲酰化以封闭最后4%的游离胺。这些困难似乎与某些批次的氯甲基树脂有关。所描述的合成中,乙炔基赖氨酸Nα - Boc - Nε - Z - L - 2,6 - 二氨基 - 4 - 己炔酸和Nα - Boc - L - 3,4 - 脱氢脯氨酸的引入没有问题。用氢氟酸裂解后,粗肽通过在Bio - Gel P2上的凝胶过滤和在羧甲基纤维素(CM 52)上的离子交换色谱进行纯化。如此获得的[Dah6,δPro7,10]-神经降压素(相对于起始的Boc - Leu - 树脂为51%)以氨基酸分析、不同系统中的薄层色谱和高效液相色谱表征为均一形式。氢化或氚化产物与天然神经降压素相同。不饱和衍生物和催化氢化后得到的神经降压素在抑制125I - [Trp11]-神经降压素与大鼠脑突触膜结合以及豚鼠回肠收缩试验中与天然神经降压素具有相同活性。用其脱氢衍生物取代脯氨酸和赖氨酸不影响神经降压素的生物学性质。氚化神经降压素(160 - 180 Ci/mmol)应该是用于神经降压素受体生物学表征和肽代谢研究的良好试剂。